A Case of Cataract Surgery without Pupillary Device in the Eye with Iridoschisis by Lee, Eun Ji et al.
Korean Journal of Ophthalmology 22(1):58-62, 2008
DOI : 10.3341/kjo.2008.22.1.58
58
Received: July 20, 2007    Accepted: November 10, 2007
Reprint requests to Jin Hak Lee, MD, PhD. Department of Ophthal-
mology, Seoul National University College of Medicine, Seoul 
National University Bundang Hospital, 300 Gumi-dong, Bundang-gu, 
Seongnam-si, Gyeonggi-do 463-707, Korea. Tel: 82-31-787-7379, 
Fax: 82-31-787-4057, E-mail: jjhlee@plaza.snu.ac.kr
* This paper has been presented in the 97th Korean Ophthal- 
mological Society Conference (in poster)
A  Case  of  Cataract  Surgery  without  Pupillary  Device  in 
the  Eye  with  Iridoschisis
Eun  Ji  Lee,  MD,
1 J i n  H a k  L e e ,  M D ,  P h D ,
2,3  Joon  Young  Hyon,  MD,  PhD,
2,3
Mee  Kum  Kim,  MD,  PhD,
1,3 W o n  R y a n g  W e e ,  M D ,  P h D ,
1,3
Department of Ophthalmology, Seoul National University College of Medicine
1, Seoul, Korea
Department of Ophthalmology, Seoul National University Bundang Hospital
2, Seongnam, Korea
Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute
3, Seoul, Korea
Purpose: To introduce a case of iridoschisis patient who underwent cataract surgery successfully without 
pupil device.
Methods: A 64-year-old female who showed iridoschisis of her both eyes underwent cataract operation at 
her right eye without a pupillary device. The preoperative and postoperative ophthalmologic examinations 
including visual acuity, intraocular pressure, reaction of anterior chamber, and degree of damage on iris was 
evaluated respectively.
Results: Cataract surgery was performed under topical anesthesia through a clear corneal incision. Iris 
fibrils were held in place by ophthalmic viscosurgical device (OVD, sodium hyaluronate 3%-sodium 
chondroitin sulfate 4%, Viscoat
Ⓡ) that was injected into the anterior chamber. A small capsulorrhexis was 
made and the nucleus was delivered with low‐power phacoemulsification, most of which was performed 
under the anterior capsule. The iris came into contact with the OVDs only and received no mechanical 
trauma. There were no intraoperative complications such as tear of the iris, hyphema, loss of mydriasis, or 
rupture of the posterior lens capsule. The edema of corneal stroma and inflammation of anterior chamber 
was shown at immediate‐postoperative period, but completely subsided 2 weeks later. The visual acuity 
showed improvement from 20/400 to 20/30.
Conclusions: In iridoschisis patients, there is a risk of aspiration of iris fibers during cataract surgery. With 
adequate use of OVD and careful modulation of surgical devices, cataract surgery was successfully 
performed without using extra pupil‐supporting device.
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Iridoschisis is a rare disease with only few cases reported.
1 
Most of the patients are over 65 years old and the condition 
is usually bilateral. The etiopathogenesis is not clearly 
understood but has most commonly been considered as an 
age‐related atrophy.
2 This condition has been associated 
with glaucoma, ocular trauma or idiopathic atrophy of the iris 
stroma.
3-6 Since Schmitt
7 first reported iris splitting into 2 
layers in 1922, there have been intermittent reports about 
iridoschisis with syphilitic interstitial keratitis, keratoconus, 
and most frequently, glaucoma.
3-6
Because iridoschisis is associated with aging,
6 cataract is 
often a concomitant issue, especially nuclear sclerotic cataract.
8 
Because it presents with 2 or more layers of iris tissue that 
is free-floating in the anterior chamber (AC), cataract 
operation in these patients needs special care.
9 Iris fibrils can 
be attracted to the phaco tip or the irrigation & aspiration 
(I&A) needle by the fluidic negative forces.
10
For protection of iris, there have been some challenges in 
cataract operation using various devices such as flexible iris 
hooks, iris retractors or pupil expanders (Graether pupil 
expander, Perfect Pupil system).
2,9,11 Vinicius et al.
12 
described a technique in which the affected anterior iris 
stroma is removed using a vitreocutter just before cataract 
extraction.
In Korea, there have been no reports since Kim et al.
13 
reported two cases in 1995, and Kwak et al.
14 reported a case 
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Fig.  1. T h e  p i c t u r e s  o f  r i g h t  e y e  ( A )  a n d  l e f t  e y e  ( B )  s h o w  s p l i t t i n g  o f  t h e  a n t e r i o r  l a y e r  o f  t h e  i r i s .
We report a case of iridoschisis patient who underwent 
cataract surgery successfully with conventional surgical 
technique, and without any additional pupil-saving device as 
the first case in Korea.
Case Report 
A 64-year-old female presented with gradual loss of vision 
in the right eye (OD) of one year duration. About six months 
ago, she had undergone intracapsular cataract extraction, 
anterior vitrectomy, and scleral fixation of intraocular lens 
(IOL) in the left eye (OS). At that time, she was suspected 
of iridocorneal endothelial syndrome (ICES).
The preoperative best corrected visual acuities (BCVA) 
were 20/400 OD, 20/30 OS. Intraocular pressures (IOP) in 
each eye were 15 mmHg by applanation. The Slit lamp 
biomicroscopy of both eyes (OU) showed clear cornea, deep 
and clear AC, and the angle was wide open. Both eyes had 
splitting of the anterior layers of the iris with fibrillar 
degeneration extending from 3 to 6 o' clock OD, and from 
4 to 6 o' clock OS. Additionally, there was diffuse atrophy 
of iris from 11 to 1 o' clock OS (Fig. 1). The underlying iris 
pigment epithelium appeared intact with no transillumination 
defect. The clinical appearance was consistent with 
iridoschisis OU. The right eye showed nuclear and cortical 
cataract associated with posterior subcapsular cataract, and 
the left eye was pseudophakia. Specular microscopy of the 
OD revealed regular, hexagonal shape of endothelial cells 
without any abnormalities like bullae or guttae, and the 
endothelial cell count was 2865 cells/mm
2. The rest of the 
ocular examination was normal.
Pupil dilation is performed using 3 drops of tropicamide 
0.5% and phenylephrine hydrochloride 0.5% at 5-minute 
intervals 1 hour prior to surgery. Intraoperative pupillary 
diameter was about 5~6 mm. Topical anesthesia was applied 
using Alcaine
Ⓡ and 3% Lidocaine, and a paracentesis was 
done at 10 o' clock. A 2.75 mm main clear corneal incision 
was performed using the keratome blade. A dispersive 
ophthalmic viscosurgical device (OVD), sodium hyaluronate 
3%-sodium chondroitin sulfate 4% (Viscoat
Ⓡ, Alcon) was 
injected through the clear corneal wound to stabilize the 
anterior chamber and protect the iris stroma by displacing 
aqueous from the AC and pushing the iris strands from the 
pupillary aperture. An anterior continuous curvilinear 
capsulorhexis not exceeding over the pupillary margin 
was performed using the 26 G needle and capsular 
forceps. After hydrodissection and hydrodelineation, careful 
phacoemulsification was performed (Allergan Sovereign
Ⓡ 
Phaco System, SOV680330) for nucleus removal with special 
care not to touch the iris tissue. Aspiration was used to clean 
residual cortical fibers from the capsular bag. When a loss 
of the protective effect of viscoelastic material was observed 
during surgery, Viscoat
Ⓡ  was reinjected additionally to 
inhibit iris fibril movement with the BSS stream.
The maximum limit of the vacuum was 300 mmHg and 
the aspiration rate, 20 cc/mmHg. The height of the irrigation 
bottle is maintained less than 60 cm to minimize the 
turbulence within the chamber. Total US time was 48 
seconds with a mean final rate of 10% of potency.
The capsular bag was inflated with viscoelastics, and a 
single-piece acrylic intraocular lens (Acry-Sof
Ⓡ  SA60AT, 
Alcon) was inserted. The IOL was safely placed in the 
capsular bag and centered, followed by aspiration of the 
residual viscoelastics. If there were some movement of iris 
fibrils, additional viscoelastics was inserted.
Finally, BSS Carbacol (carbachol 0.01%, Miostat
Ⓡ) was 
used to constrict the pupil.
Postoperatively, the inflammatory response in the AC was 
moderate, some fibrillar materials were seen. The cornea 
showed some Descemet folds, and the pupil was round and 
undamaged (Fig. 2).
One week after surgery, the uncorrected visual acuity was 
20/100 OD, and improved to 20/30 on the two weeks 
postoperative day. There were traces of cells in the AC, but 
no fibrillar materials were seen (Fig. 3).
The patient’s last visit was 1 month after surgery when 
UCVA was 20/40, and BCVA 20/20. The cornea, AC and 
iris were clear and intact without any inflammatory sequalae.
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Fig.  2. T h r e e  d a y s  a f t e r  c a t a r a c t  o p e r a t i o n ,  c o r n e a l  s t r o m a l  
edema  and  inflammation  of  anterior  chamber  began  to  decrease.
Fig.  3.  Six  days  after  cataract  operation,  cornea  and  anterior 
chamber  became  almost  clear.
Discussion
Iridoschisis is a very rare condition resulting in one or 
more layers of the anterior iris surface. A localized area of 
iris stroma is cleaved in two with the anterior atrophic 
portion disintegrating into fibrils. The separated stromal 
fibers go through a degenerative process in which they detach 
and free float in the anterior chamber, creating a "shredded 
wheat" appearance. The condition primarily affects the 
inferior iris quadrants and rarely superior quadrants.
9-13
Glaucoma occurs in 50% of the cases and is of the angle 
closure type.
15 Whether iris changes are responsible or 
iridoschisis occurs more frequently in eyes that are 
predisposed to angle closure is unclear.
16 While primary 
angle closure glaucoma has been implicated in iridoschisis 
formation, the affected fibers may bow forward, leading to 
anterior synechiae and angle closure glaucoma.
5,6,14,15 In the 
present case, the anterior chamber angle was wide open and 
the IOP were within normal limits.
It is a matter of concern that the clinicians are prone to 
misdiagnose this condition, especially in the case with dark 
colored iris. It may be related to relatively low incidence in 
Asian race. In Korea, there have been only three cases of 
report in 1990's.
13,14 Differential diagnosis must include 
Axenfeld‐Reiger anomaly, ICES, or other conditions which 
accompany the degenerative change of iris stroma.
An abnormal corneal endothelium that migrates across the 
chamber angle on to the surface of the iris is the common 
feature of the ICE syndromes.
17 The iris in ICES is usually 
atrophic rather than split, and peripheral anterior synechiae 
(PAS) extends to Schwalbe’s line. The pupil may be ectopic 
and displaced towards PAS. Specular microscopy has shown 
the abnormal corneal endothelial cells, so called "ICE cells", 
which are pleomorphic and resemble corneal guttata. It 
occurs mostly unilateral and the clinical symptoms are 
presented earlier than iridoschisis (about 3
rd or 4
th decades). 
Axenfeld-Rieger syndrome is a rare congenital anomaly 
which is presented at birth. There is hypoplasia of the iris 
stroma with filaments connected to abnormal peripheral 
cornea.
18 In this case, the clinical features most coincidence 
with iridoschisis, rather than ICES or Axenfeld‐Reiger 
syndrome. The onset of symptom was over 60 years of age. 
The condition was bilateral and there was no PAS or 
connection of iris fibrils with peripheral cornea. Specular 
microscopy showed normal shape and count of corneal 
endothelial cells. Considering that our patient had been 
diagnosed as bilateral ICES before, there may have been 
other misdiagnosed and unreported cases.
Because iridoschisis is associated with aging, cataract is 
often a concomitant issue.
2 The disorganized anterior layer of 
the iris and fibrillar material in the pupillary axis has a 
tendency to become drawn in by the suction of the I/A 
cannula and phaco tip during phacoemulsification. Pupil 
dilation in these patients is also poor because this condition 
may be associated with pseudoexfoliation syndrome or 
atrophy of the pupillary margin.
11
If the loose iris fibrils become drawn and entrapped in the 
aspiration port, there is a strong chance of complications like 
bleeding, iris tears, loss of mydriasis, and disruption of the 
blood-aqueous barrier.
9 Many methods have been tried to 
stabilize the iris fibers during cataract operation in the 
presence of iridoschisis. Most of them are based on 
mechanical restraint of the disorganized iris using flexible iris 
hooks, iris retractors or pupil expanders, such as multiple iris 
hooks or Graether pupil expander.
2,9,11,12
These mechanical supports provide additional pupillary 
dilation, stabilize the capsule, and trap some of the fibers at 
pupillary margin during phacoemulsification. But these 
supportive devices can also induce strain and trauma to iris 
tissue resulting in increased inflammation after postoperative 
period. Sometimes they lead to defects in the pupillary 
margin or to an atonic pupil.
11 Moreover, long, free-floating, 
torn fibers may not be trapped and may still extend over the 
rim into the surgical field.
9 In withdrawing these instruments, 
iris fibers can be trapped in the stab incisions, and such 
fibers may act as an entrance for epithelial cells and 
micro-organisms.
9
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Vacuum  (mmHg) Aspiration  (cc/mmHg) Bottle  height  (cm)
Conventional  surgery
* Chopping 340 34 100
Cortex  removal 550 32 100
Polish 20 10 85
Viscoat  removal 550 40 90
For  iridoschisis
† Total
‡ 300 30 60
* The  maximum  limits  of  fluidic  parameters  which  are  preferred  by  author. 
†The  resultant  maximum  values  shown  in 
the text. 
‡The maximum value in total process was obtained instead of the individual values. (Polishing mode was not 
introduced  in  this  case.)
Table  1.  The  maximum  limits  of  fluidic  parameters  set  in  cataract  surgery  with  Allergan  Sovereign
Ⓡ  Phaco  System
minimized the iris trauma through the right choice of the 
viscoelastic material, careful manipulation of phaco tip or 
I&A cannula, and reducing the turbulence by using the 
minimum required fluidic parameters achieved with lowering 
the total phaco power and the height of the irrigation bottle. 
The Allergan Sovereign
Ⓡ Phaco System has a peristaltic 
fluidic pump system with vacuum range of 0~500 mmHg and 
flow range of 0~40 cc/min. The maximal fluidic parameters 
showed in the presented case were relatively lower than the 
values that had been usually set for conventional cataract 
surgery. The detail values are shown in Table 1.
As an OVD, sodium hyaluronate 3%-sodium chondroitin 
sulfate 4% (Viscoat
Ⓡ) was chosen. Viscoat
Ⓡ has been known 
to have a very high dynamic viscosity at high shear rate. This 
property and a poor cohesion provide a better corneal 
endothelial protection during in vitro phacoemulsification. 
19,20 Although the removal time of OVD is longer with 
dispersive Viscoat
Ⓡ than other cohesive OVDs (sodium 
hyaluronate 1.4%, Healon GV




Ⓡ is less influenced by turbulent flow 
while cohesive OVDs tend to be washed out suddenly which 
could result in sudden collapse of anterior chamber.
21,22 
Furthermore, the cohesive OVD fragment behind the IOL is 
exposed to too little turbulent flow to move towards the 
aspiration port unless the I&A tip is placed behind the IOL 
or a special technique is used.
23
A small capsulorhexis that did not extend vertically 
beyond the middle of the pupil was performed deliberately 
to allow he anterior capsule to act as an additional barrier 
between the iris and instruments.
To protect the friable and disorganized iris from further 
damage, the instruments were manipulated only in the 
pupillary center. If a loss of the protective effect or the 
movement of iris fibril were observed, the OVD was injected 
additionally.
The machine settings, including flow rate and vacuum 
limit, as well as port diameter are different between 
phacoemulsification needle and I/A tip. The former is related 
to the retention ability of OVDs and the latter to removal 
property.
23 Although we were not able to manage the 
diameter of phaco or I&A tips, the minimum possible amount 
of US energy, BSS flow rate and vacuum limit enabled the 
surgical procedures to be performed under safer environment.
There was no iris trauma, intraoperative iris bleeding, or 
posterior capsular rupture during surgery. The corneal edema 
had disappeared by two weeks after surgery, and the AC 
inflammation had subsided after one month postoperatively. 
The final BCVA OD had improved from the preoperative 
one, from 20/400 to 20/20.
This is a case which emphasizes the importance of 
exact preoperative diagnosis and differential diagnosis in 
iridoschisis. In the absence of proper clinical impression and 
proper preoperative preparation, surgeons may not have been 
able to manage the various intraoperative complications. Our 
patient had been diagnosed as ICES, and underwent ICCE, 
anterior vitrectomy and scleral fixation of IOL on the 
contralateral eye (OS).
In conclusion, for iridoschisis is a very rare condition and 
easy to be confused with other diseases, one must consider 
this condition into differential diagnosis if the iris 
abnormalities are suspicious.
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